Fingerprint
Dive into the research topics of 'Survival benefit with imatinib mesylate versus interferon-α-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically